Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic €32.70 /Month

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Rent this article via DeepDyve

Similar content being viewed by others

Iontophoretic Transport Mechanisms and Factors Affecting Electrically Assisted Delivery

Chapter © 2017

Combined Use of Iontophoresis and Other Physical Methods

Chapter © 2017

Therapeutic Applications of Electroporation

Chapter © 2017

Data availability

This material has not been published in whole or in part elsewhere.

References

  1. Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015;172(9):2179–209. ArticleCASPubMedPubMed CentralGoogle Scholar
  2. Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1–2):12–21. ArticleCASPubMedGoogle Scholar
  3. Ita K. Recent progress in transdermal sonophoresis. Pharm Dev Technol. 2017a;22(4):458–66. ArticleCASPubMedGoogle Scholar
  4. Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta. 2009;1788(11):2362–73. ArticleCASPubMedGoogle Scholar
  5. Hadgraft J, Lane ME. Passive transdermal drug delivery systems. Am J Drug Deliv. 2006;4(3):153–60. ArticleCASGoogle Scholar
  6. Watkinson AC, Kearney MC, Quinn HL, Courtenay AJ, Donnelly RF. Future of the transdermal drug delivery market-have we barely touched the surface? Expert Opin Drug Deliv. 2016;13(4):523–32. ArticleCASPubMedGoogle Scholar
  7. Thotakura N, Kaushik L, Kumar V, Preet S, Babu PV. Advanced approaches of bioactive peptide molecules and protein drug delivery systems. Curr Pharm Des. 2018;24(43):5147–63. ArticleCASPubMedGoogle Scholar
  8. Dixit N, Bali V, Baboota S, Ahuja A, Ali J. Iontophoresis - an approach for controlled drug delivery: a review. Curr Drug Deliv. 2007;4(1):1–10. CASPubMedGoogle Scholar
  9. Ajay KB, Peter CP. lontophoretic devices: clinical applications and rehabilitation medicine. Crit Rev Phys Rehabil Med. 2017;29(1–4):247–79. Google Scholar
  10. Ita K. Transdermal iontophoretic drug delivery: advances and challenges. J Drug Target. 2016;24(5):386–91. ArticleCASPubMedGoogle Scholar
  11. Ita K. Percutaneous transport of psychotropic agents. J Drug Deliv Sci Technol. 2017b;39:247–59. ArticleCASGoogle Scholar
  12. Petrilli R, Lopez RFV. Physical methods for topical skin drug delivery: concepts and applications. Braz J Pharm Sci. 2018;54.
  13. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56:619–58. ArticleCASPubMedGoogle Scholar
  14. Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev. 2001;46(1–3):281–305. ArticleCASPubMedGoogle Scholar
  15. Dhote V, Bhatnagar P, Mishra PK, Mahajan SC, Mishra DK. Iontophoresis: a potential emergence of a transdermal drug delivery system. Sci Pharm. 2012;80(1):1–28. ArticleCASPubMedGoogle Scholar
  16. Manabe E, Numajiri S, Sugibayashi K, Morimoto Y. Analysis of skin permeation-enhancing mechanism of iontophoresis using hydrodynamic pore theory. J Control Release. 2000;66(2–3):149–58. ArticleCASPubMedGoogle Scholar
  17. Arunkumar S, Ashok P, Desai BG, Shivakumar HN. Effect of chemical penetration enhancer on transdermal iontophoretic delivery of diclofenac sodium under constant voltage. J Drug Deliv Sci Technol. 2015;30:171–9. ArticleCASGoogle Scholar
  18. Djabri A, Guy RH, Delgado-Charro MB. Passive and iontophoretic transdermal delivery of phenobarbital: implications in paediatric therapy. Int J Pharm. 2012;435(1):76–82. ArticleCASPubMedGoogle Scholar
  19. Kalaria DR, Singhal M, Patravale V, Merino V, Kalia YN. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: transdermal polypharmacy to treat Parkinson’s disease. Eur J Pharm Biopharm. 2018;127:204–12. ArticleCASPubMedGoogle Scholar
  20. Gratieri T, Kalia YN. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier. Adv Drug Deliv Rev. 2013;65:315–29. ArticleCASPubMedGoogle Scholar
  21. Cordery SF, Husbands SM, Bailey CP, Guy RH, Delgado-Charro MB. Simultaneous transdermal delivery of buprenorphine hydrochloride and naltrexone hydrochloride by iontophoresis. Mol Pharm. 2019;16(6):2808–16. ArticleCASPubMedGoogle Scholar
  22. Patel N, Jain S, Lin S. Transdermal iontophoretic delivery of tacrine hydrochloride: correlation between in vitro permeation and in vivo performance in rats. Int J Pharm. 2016;513(1–2):393–403. ArticleCASPubMedGoogle Scholar
  23. Djabri A, Guy RH, Delgado-Charro MB. Potential of iontophoresis as a drug delivery method for midazolam in pediatrics. Eur J Pharm Sci. 2019;128:137–43. ArticleCASPubMedGoogle Scholar
  24. Ita KB, Banga AK. In vitro transdermal iontophoretic delivery of penbutolol sulfate. Drug Deliv. 2009;16(1):11–4. ArticleCASPubMedGoogle Scholar
  25. Wang Y, Thakur R, Fan Q, Michniak B. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm. 2005;60(2):179–91. ArticleCASPubMedGoogle Scholar
  26. Ita K. Transcutaneous permeation of antiviral agents. J Drug Deliv Sci Technol. 2017c;41:293–302. ArticleCASGoogle Scholar
  27. Rac V, Levic S, Balanc B, Olalde Graells B, Bijelic G. PVA Cryogel as model hydrogel for iontophoretic transdermal drug delivery investigations. Comparison with PAA/PVA and PAA/PVP interpenetrating networks. Colloids Surf B Biointerfaces. 2019;180:441–8. ArticleCASPubMedGoogle Scholar
  28. Ferreira JA, de Oliveira P, Pena G. Transdermal iontophoresis—a quantitative and qualitative study. Comput Math Appl. 2017;74(10):2231–42. ArticleGoogle Scholar
  29. Bashyal S, Lee S. Delivery of biopharmaceuticals using combination of liposome and iontophoresis: a review. J Pharm Invest. 2015;45(7):611–24. ArticleCASGoogle Scholar
  30. Subramony JA, Sharma A, Phipps JB. Microprocessor controlled transdermal drug delivery. Int J Pharm. 2006;317:1–6. ArticleCASPubMedGoogle Scholar
  31. Marwah H, Garg T, Goyal AK, Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2016;23(2):564–78. ArticleCASPubMedGoogle Scholar
  32. Del Río-Sancho S, Serna-Jimenez CE, Sebastian-Morello M, Calatayud-Pascual MA, Balaguer-Fernandez C, Femenia-Font A, Kalia YN, Merino V, Lopez-Castellano A. Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport. Int J Pharm. 2017;517(1–2):104–11. ArticlePubMedGoogle Scholar
  33. Serna-Jiménez CE, del Rio SS, Calatayud-Pascual MA, Balaguer-Fernndez C, Femena-Font A, Lpez-Castellano A, Merino V. Development of antimigraine transdermal delivery systems of pizotifen malate. Int J Pharmaceut. 2015;492(1–2):223–32. ArticleGoogle Scholar
  34. Calatayud-Pascual MA, Sebastian-Morelló M, Balaguer-Fernández C, Delgado-Charro MB, López-Castellano A, Merino V. Influence of chemical enhancers and iontophoresis on the in vitro transdermal permeation of propranolol evaluation by dermatopharmacokinetics. Pharmaceutics. 2018;10(4).
  35. Puri A, Murnane KS, Blough BE, Banga AK. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride. Int J Pharm. 2017;528(1–2):452–62. ArticleCASPubMedGoogle Scholar
  36. Arunkumar S, Shivakumar HN, Narasimha MS. Effect of terpenes on transdermal iontophoretic delivery of diclofenac potassium under constant voltage. Pharm Dev Technol. 2018;23(8):806–14. ArticleCASPubMedGoogle Scholar
  37. Murari BM, Singh S, Manoharan M. Transdermal delivery of polidocanol from sol–gel patch: ex vivo skin permeation studies using iontophoresis for the treatment of varicose veins. J Sol-Gel Sci Technol. 2018;87(3):639–46. ArticleCASGoogle Scholar
  38. Nguyen HX, Banga AK. Electrically and ultrasonically enhanced transdermal delivery of methotrexate. Pharmaceutics. 2018;10(3):117. ArticleCASPubMed CentralGoogle Scholar
  39. Zuo J, Du L, Li M, Liu B, Zhu W, Jin Y. Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs. Int J Pharm. 2014;466(1–2):76–82. ArticleCASPubMedGoogle Scholar
  40. Kazemi M, Mombeiny R, Tavakol S, Keyhanvar P, Mousavizadeh K. A combination therapy of nanoethosomal piroxicam formulation along with iontophoresis as an anti-inflammatory transdermal delivery system for wound healing. Int Wound J. 2019;16(5):1144–52. ArticlePubMedPubMed CentralGoogle Scholar
  41. Liu S, Bao X, Zhang S, Zhang H, Lu X, Li T, Chen Z, Chen N. The study of ultrasound and iontophoresis on oxaprozin transdermal penetration using surface-enhanced Raman spectroscopy. Drug Deliv Transl Res. 2020;10:83–92. ArticleCASPubMedGoogle Scholar
  42. Singhal M, Merino V, Rosini M, Cavalli A, Kalia YN. Controlled Iontophoretic delivery in vitro and in vivo of ARN14140— a multitarget compound for Alzheimer’s disease. Mol Pharm. 2019;16(8):3460–8. ArticleCASPubMedGoogle Scholar
  43. Alvarez-Figueroa MJ, Delgado-Charro MB, Blanco-Mndez J. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm. 2001;212(1):101–7. ArticleCASPubMedGoogle Scholar
  44. Tfaili S, Gobinet C, Josse G, Angiboust JF, Manfait M, Piot O. Confocal Raman microspectroscopy for skin characterization: a comparative study between human skin and pig skin. Analyst. 2012;137(16):3673–82. ArticleCASPubMedGoogle Scholar
  45. Takeuchi I, Suzuki T, Makino K. Skin permeability and transdermal delivery route of 50-nm indomethacin-loaded PLGA nanoparticles. Colloids Surf B Biointerfaces. 2017;159:312–7. ArticleCASPubMedGoogle Scholar
  46. Cazares-Delgadillo J, Balaguer-Fernandez C, Calatayud-Pascual A, Ganem-Rondero A, Quintanar-Guerrero D, Lopez-Castellano AC, Merino V, Kalia YN. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics. Eur J Pharm Biopharm. 2010;75(2):173–8. ArticleCASPubMedGoogle Scholar
  47. Santos LF, Correia IJ, Silva AS, Mano JF. Biomaterials for drug delivery patches. Eur J Pharm Sci. 2018;118:49–66. ArticleCASPubMedGoogle Scholar
  48. Talbi Y, Campo E, Brulin D, Fourniols JY. Controllable and re-usable patch for transdermal iontophoresis drug delivery. Electron Lett. 2018;54(12):739–40. ArticleCASGoogle Scholar
  49. Karjalainen E, Repasky GA. Molecular changes during acute myeloid leukemia (AML) evolution and identification of novel treatment strategies through molecular stratification. Prog Mol Biol Transl Sci. 2016;144:383–436. ArticleCASPubMedGoogle Scholar
  50. Cazares-Delgadillo J, Ganem-Rondero A, Merino V, Kalia YN. Controlled transdermal iontophoresis for poly-pharmacotherapy: simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo. Eur J Pharm Sci. 2016;85:31–8. ArticleCASPubMedGoogle Scholar
  51. Juluri A, Narasimha Murthy S. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin. J Control Release. 2014.
  52. Hegde AR, Rewatkar PV, Manikkath J, Tupally K, Parekh HS, Mutalik S. Peptide dendrimer-conjugates of ketoprofen: Synthesis and ex vivo and in vivo evaluations of passive diffusion, sonophoresis and iontophoresis for skin delivery. Eur J Pharm Sci. 2017;102:237–49. ArticleCASPubMedGoogle Scholar
  53. Reis TA, Jaculi AE, Ramos KLV, Souza PEN, Veiga-Souza FH, Joanitti GA, Azevedo RB, Gratieri T, Cunha-Filho M, Gelfuso GM. Combination of cyclodextrin complexation and iontophoresis as a promising strategy for the cutaneous delivery of aluminum-chloride phthalocyanine in photodynamic therapy. Eur J Pharm Sci. 2019;139.
  54. Shiota K, Hama S, Yoshitomi T, Nagasaki Y, Kogure K. Prevention of UV-induced melanin production by accumulation of redox nanoparticles in the epidermal layer via iontophoresis. Biol Pharm Bull. 2017;40(6):941–4. ArticleCASPubMedGoogle Scholar
  55. Park J, Lee H, Lim GS, Kim N, Kim D, Kim YC. Enhanced transdermal drug delivery by sonophoresis and simultaneous application of sonophoresis and iontophoresis. AAPS PharmSciTech. 2019;20(3).
  56. Bajracharya R, Song JG, Back SY, Han HK. Recent advancements in non-invasive formulations for protein drug delivery. Comput Struct Biotechnol J. 2019;17:1290–308. ArticleCASPubMedPubMed CentralGoogle Scholar
  57. Pawar K, Kolli CS, Rangari VK, Babu RJ. Transdermal iontophoretic delivery of lysine-proline-valine (KPV) peptide across microporated human skin. J Pharm Sci. 2017;106(7):1814–20. ArticleCASPubMedGoogle Scholar
  58. Yu T, Zhang S, Cao X, Liu C. Iontophoretic delivery of transdermal patches containing ropivacaine: sustaining the anesthetic effect in children. Acta Biochim Pol. 2019;66(2):167–72. CASPubMedGoogle Scholar
  59. Lee J, Kwon K, Kim M, Min J, Hwang NS, Kim WS. Transdermal iontophoresis patch with reverse electrodialysis. Drug Deliv. 2017;24(1):701–6. ArticleCASPubMedPubMed CentralGoogle Scholar
  60. Kim KT, Lee J, Kim MH, Park JH, Lee JY, Song JH, Jung M, Jang MH, Cho HJ, Yoon IS, Kim DD. Novel reverse electrodialysis-driven iontophoretic system for topical and transdermal delivery of poorly permeable therapeutic agents. Drug Deliv. 2017;24(1):1204–15. ArticleCASPubMedPubMed CentralGoogle Scholar
  61. Noh G, Keum T, Seo JE, Bashyal S, Eum NS, Kweon MJ, Lee S, Sohn DH, Lee S. Iontophoretic transdermal delivery of human growth hormone (hGH) and the combination effect of a new type microneedle, Tappy Tok Tok®. Pharmaceutics. 2018;10(3):153. ArticleCASPubMed CentralGoogle Scholar
  62. Hashim IIA, Motoyama K, Abd-Elgawad AEH, El-Shabouri MH, Borg TM, Arima H. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides. Int J Pharm. 2010;393(1–2):127–34. PubMedGoogle Scholar
  63. Ita K. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles. Biomed Pharmacother. 2017d;87:311–20. ArticleCASPubMedGoogle Scholar
  64. Tezel A, Dokka S, Kelly S, Hardee GE, Mitragotri S. Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis. Pharm Res. 2004;21:2219–25. ArticleCASPubMedGoogle Scholar
  65. Tokumoto S, Higo N, Todo H, Sugibayashi K. Effect of combination of low-frequency sonophoresis or electroporation with iontophoresis on the mannitol flux or electroosmosis through excised skin. Biol Pharm Bull. 2016;39(7):1206–10. ArticleCASPubMedGoogle Scholar
  66. Arunkumar S, Shivakumar HN, Desai BG, Ashok P. Effect of gel properties on transdermal iontophoretic delivery of diclofenac sodium. E-Polymers. 2016;16(1):25–32. ArticleCASGoogle Scholar
  67. Liu KC, Green CR, Alany RG, Rupenthal ID. Synergistic effect of chemical penetration enhancer and iontophoresis on transappendageal transport of oligodeoxynucleotides. Int J Pharm. 2013;441(1–2):687–92. ArticleCASPubMedGoogle Scholar
  68. Munch S, Wohlrab J, Neubert RHH. Dermal and transdermal delivery of pharmaceutically relevant macromolecules. Eur J Pharm Biopharm. 2017;119:235–42. ArticleCASPubMedGoogle Scholar
  69. Ronnander JP, Simon L, Koch A. Transdermal delivery of sumatriptan succinate using iontophoresis and dissolving microneedles. J Pharm Sci. 2019;108(11):3649–56. ArticleCASPubMedGoogle Scholar
  70. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–8. ArticleCASPubMedPubMed CentralGoogle Scholar
  71. Fatima T, Ajjarapu S, Shankar VK, Rangappa S, Shivakumar HN, Biswas SK, Hoque M, Murthy SN. Topical pilocarpine formulation for diagnosis of cystic fibrosis. J Pharm Sci. 2020;109(5):1747–51. ArticleCASPubMedGoogle Scholar
  72. Dagash H, McCaffrey S, Mellor K, Roycroft A, Helbling I. Tap water iontophoresis in the treatment of pediatric hyperhidrosis. J Pediatr Surg. 2017;52(2):309–12. ArticlePubMedGoogle Scholar
  73. Dogruk Kacar S, Ozuguz P, Eroglu S, Polat S, Karaca S. Treatment of primary hyperhidrosis with tap water iontophoresis in paediatric patients: a retrospective analysis. Cutan Ocul Toxicol. 2014;33(4):313–6. ArticleCASPubMedGoogle Scholar
  74. Choi D-H, Thaxton A, Jeong IC, Kim K, Sosnay PR, Cutting GR, Searson PC. Sweat test for cystic fibrosis: wearable sweat sensor vs. standard laboratory test. J Cyst Fibros. 2018;17(4):e35–8. ArticlePubMedGoogle Scholar
  75. Korsten MA, Lyons BL, Radulovic M, Cummings TM, Sikka G, Singh K, Hobson JC, Sabiev A, Spungen AM, Bauman WA. Delivery of neostigmine and glycopyrrolate by iontophoresis: a nonrandomized study in individuals with spinal cord injury. Spinal Cord. 2018;56(3):212–7. ArticlePubMedGoogle Scholar
  76. Gaillard-Bigot F, Roustit M, Blaise S, Cracowski C, Seinturier C, Imbert B, Carpentier P, Cracowski JL. Treprostinil iontophoresis improves digital blood flow during local cooling in systemic sclerosis. Microcirculation. 2016;23(3):266–70. ArticleCASPubMedGoogle Scholar
  77. Andanooru Chandrappa NK, Channakeshavaiah Ravikumar B, Rangegowda SM. Iontophoretic delivery of methotrexate in the treatment of palmar psoriasis: a randomised controlled study. Australas J Dermatol. 2020.
  78. Jijie R, Barras A, Boukherroub R, Szunerits S. Nanomaterials for transdermal drug delivery: beyond the state of the art of liposomal structures. J Mater Chem B. 2017;5(44):8653–75. ArticleCASPubMedGoogle Scholar
  79. Zhang Y, Yu J, Kahkoska AR, Wang J, Buse JB, Gu Z. Advances in transdermal insulin delivery. Adv Drug Deliv Rev. 2019;139:51–70. ArticleCASPubMedGoogle Scholar
  80. Dubey S, Kalia YN. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1. J Control Release. 2011;152(3):356-362.
  81. Merino V, Kalia YN, Guy RH. Transdermal therapy and diagnosis by iontophoresis. Trends Biotechnol. 1997;15(8):288–90. ArticleCASPubMedGoogle Scholar

Acknowledgements

Acknowledge any further contributions to this paper.